Chronic hepatitis B: who to treat and which choice of treatment?
about
Rational design of immunostimulatory siRNAs.Functional Characterization of Interferon Regulation Element of Hepatitis B virus Genome In Vivo.Differential impact of immune escape mutations G145R and P120T on the replication of lamivudine-resistant hepatitis B virus e antigen-positive and -negative strains.Perspectives on the management of chronic hepatitis B and C.Prevalence of hepatitis B surface antigen among refugees entering the United States between 2006 and 2008.
P2860
Chronic hepatitis B: who to treat and which choice of treatment?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Chronic hepatitis B: who to treat and which choice of treatment?
@en
Chronic hepatitis B: who to treat and which choice of treatment?
@nl
type
label
Chronic hepatitis B: who to treat and which choice of treatment?
@en
Chronic hepatitis B: who to treat and which choice of treatment?
@nl
prefLabel
Chronic hepatitis B: who to treat and which choice of treatment?
@en
Chronic hepatitis B: who to treat and which choice of treatment?
@nl
P2860
P356
P1476
Chronic hepatitis B: who to treat and which choice of treatment?
@en
P2093
Antonio Craxì
Vito Di Marco
P2860
P304
P356
10.1586/ERI.09.4
P577
2009-04-01T00:00:00Z